CUAMC
CADL icon

China Universal Asset Management Company’s Candel Therapeutics CADL Stock Holding History

China Universal Asset Management Company’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
11,661
-1,337
-10% -$10.1K 0.01% 399
2026
Q1 		$63.7K Buy
12,998
+4,052
+45% +$22.1K ﹤0.01% 446
2025
Q4 		$50.5K Buy
+8,946
New +$48.1K ﹤0.01% 450
2022
Q4 		– Sell
-271
Closed -$1K – 406
2022
Q3 		$1K Buy
+271
New +$918 ﹤0.01% 385

Other funds holding CADL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

China Universal Asset Management Company's CADL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Candel Therapeutics (CADL) stake by 10% in Q2 2026, selling an estimated $10.1K and leaving 11,661 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #399.

China Universal Asset Management Company first reported a position in CADL in Q3 2022 and has held it in 4 quarters since. 72 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • China Universal Asset Management Company held 11,661 shares of Candel Therapeutics worth $120K as of Q2 2026.
  • China Universal Asset Management Company sold 1,337 Candel Therapeutics shares in Q2 2026, an estimated $10.1K.
  • Candel Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #399 holding.
  • China Universal Asset Management Company first reported a position in Candel Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • 72 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.